Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Routine +

Great West reports double-digit growth and base ROE above 19%

Great-West Lifeco Hits ROE Target as Earnings Momentum Sustains

Executive Summary
  • Event: Q1 2026 Earnings Release (May 6, 2026).
  • Headline: Double-digit growth and base ROE above 19%.
  • Financial Performance:
    • Base earnings: $1,239 million (+20% YoY).
    • Net earnings: $1,192 million (+39% YoY).
    • Base EPS: $1.37 (+23% YoY).
    • Base ROE: 19.1% (Achieved medium-term objective).
  • Capital Management:
    • Share repurchases: $567 million in Q1.
    • Dividend: $0.67 per share approved (consistent with Feb 2026 announcement).
    • LICAT ratio: 129% (down from 131% in Q3 2025, but well above requirement).
  • Segment Performance:
    • U.S.: $430 million (+18%).
    • Canada: $352 million (+11%).
    • Europe: $273 million (+14%, recovery from -2% in Q4 2025).
    • Capital and Risk Solutions (CRS): $300 million (+41%).
  • Assets: Total client assets reached $3.3 trillion.
Material Impact
  • Expectation vs. Reality: The results align with the strong momentum established in Q4 2025 and FY2025 announcements (Feb 2026). The market had already priced in significant growth given the stock's ~45% appreciation from June 2025 lows to May 2026 highs.
  • ROE Milestone: Achieving a base ROE of 19.1% confirms the medium-term financial objective stated in previous quarters. While positive, this was anticipated based on the trajectory set in late 2025.
  • Capital Return: The $567 million buyback in Q1 is consistent with the renewed NCIB program announced in Jan 2026 ($20 million shares authorized). It signals confidence but does not represent a new strategic shift.
  • Risk Consideration: The LICAT ratio dipped slightly to 129% from 131% (Q3) and 128% (Q4), indicating capital deployment is active. While safe, it requires monitoring if regulatory requirements tighten or market volatility increases.
  • Conclusion: This is a confirmation of the existing growth thesis rather than a new catalyst. The stock has already rallied significantly on this news flow since February.
GWO · Price
Company Overview
  • Overview: Great-West Lifeco Inc. is a leading international financial services organization with operations in Canada, the U.S., Europe, and Asia. It operates through segments including Insurance, Wealth Management (Empower), and Capital & Risk Solutions.
  • Flagship Project/Unit: Empower (U.S. Retirement and Wealth). This unit drives significant growth via net plan flows ($5.3 billion in Q1 2026) and asset accumulation ($2 trillion AUA as of Feb 2026).
  • Development: The company has successfully pivoted towards higher-margin wealth management businesses, evidenced by the CRS segment growing 41% and U.S. Wealth flows accelerating.
Read the original news release →

More from GREAT-WEST LIFECO INC.